MIRA stock news · MIRA Pharmaceuticals
Get alerts for MIRA
Follow MIRA Pharmaceuticals (MIRA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MIRAMIRA Pharmaceuticals got the green light from the DEA to keep developing its main drug candidates.
Good for MIRAThe DEA confirmed MIRA’s three lead drug candidates are not controlled substances. This is a positive step for development, though all three programs still need more study.
Mira Pharmaceuticals, Inc. shares good news about MIRA-55's promise for treating long-lasting pain.
Good for MIRAMira Pharmaceuticals reported animal-study results for MIRA-55 that support its progress, but the medicine has not yet been tested in people.
12 health care stocks changed a lot during Monday's after-hours trading.
NeutralMira Pharmaceuticals shares fell 6.69% to $0.82 after hours, but the item reports only a market move and no company-level news to change the outlook.
On Friday evening, 12 health care stocks saw big changes in their prices.
NeutralMira Pharmaceuticals shares decreased 6.29% to $0.78 after-market. The article gives only price data, so it does not change Mira's prospects.
MIRA Pharmaceuticals, Inc. asked its shareholders to vote on important issues.
NeutralMIRA held its annual meeting; shareholders approved directors and the auditor. This routine filing does not change the company's outlook.